date_of_sample	date_of_plate_submission	patient_id	sanger_sample_id	sex	age	biopsy_type	disease_status	inflammation_status	cd_type	smoking_status	endoscopist	collection_time	chromium_time	experimentalist	epithelial_immune_ratio	protocol	collagenase	inhibitor	DNase	ack_lysis_buffer	frozen_processed	chip_well_position	enzyme_lot	bead_version	bead_lot	chip_version	chip_lot	id_run	lane	library_id	library_type	manual_qc	study	study_id	total_reads	biopsy_type_original	disease_status_original	time_to_chromium_processing	sample_status	Estimated.Number.of.Cells	Mean.Reads.per.Cell	Median.Genes.per.Cell	Number.of.Reads	Valid.Barcodes	Sequencing.Saturation	Q30.Bases.in.Barcode	Q30.Bases.in.RNA.Read	Q30.Bases.in.Sample.Index	Q30.Bases.in.UMI	Reads.Mapped.to.Genome	Reads.Mapped.Confidently.to.Genome	Reads.Mapped.Confidently.to.Intergenic.Regions	Reads.Mapped.Confidently.to.Intronic.Regions	Reads.Mapped.Confidently.to.Exonic.Regions	Reads.Mapped.Confidently.to.Transcriptome	Reads.Mapped.Antisense.to.Gene	Fraction.Reads.in.Cells	Total.Genes.Detected	Median.UMI.Counts.per.Cell
07-01-2020	2020-01-08	07-01-2010-001	OTARscRNA8355918	F	65	TI	Healthy	uninflamed	NA	no	NA	09:48:00	14:00:00	Menna	1:1	tissue_v2	worthington	QR	stemcell_RT	yes	no	1	SLBZ4589	V3	154140	chip-b	153745	33028	3	28621903	Chromium single cell 3 prime v3	1	HG_ Mapping genetic variants underlying gene regulation in healthy intestinal cell types to identify novel IBD drug targets	5819	206014004	ti	healthy	04:12:00	Sequenced + Cell Ranger	3399	104500	1603	355197557	98.3%	83.4%	96.3%	74.3%	93.9%	96.6%	93.6%	89.6%	5.1%	24.0%	60.6%	56.9%	1.4%	90.1%	22517	4800
2020-01-16	2020-01-17	16-01-2020-001	OTARscRNA8356014	M	53	TI	Healthy	uninflamed	NA	ex-smoker	NA	10:53:00	15:00:00	Menna	1:1	tissue_v2	worthington	QR	stemcell_RT	yes	no	1	SLBZ4589	V3	154140	chip-b	153745	33028	6	29048755	Chromium single cell 3 prime v3	1	HG_ Mapping genetic variants underlying gene regulation in healthy intestinal cell types to identify novel IBD drug targets	5819	179113356	ti	healthy	04:07:00	Sequenced + Cell Ranger	4305	86055	1337	370466898	98.2%	74.2%	96.9%	80.0%	94.8%	97.1%	94.3%	91.1%	5.5%	23.9%	61.6%	58.1%	1.7%	78.5%	22868	4238
2020-01-22	2020-01-23	22-01-2020-001	OTARscRNA8356110	F	51	TI	Healthy	uninflamed	NA	no	NA	10:23:00	15:00:00	Menna	1:0	tissue_v2	worthington	QR	stemcell_RT	yes	no	1	SLBZ4589	V3.1	154287	chip-g	154412	33380	3	29107089	Chromium single cell 3 prime v3	1	HG_ Mapping genetic variants underlying gene regulation in healthy intestinal cell types to identify novel IBD drug targets	5819	290873756	ti	healthy	04:37:00	Sequenced + Cell Ranger	6036	63635	1331	384106716	97.4%	63.7%	98.6%	81.6%	97.0%	98.5%	94.6%	90.0%	5.3%	23.0%	61.7%	57.3%	2.3%	87.4%	24048	3820
2020-01-31	2020-01-31	31-01-2020-001	OTARscRNA8356302	M	54	TI	Healthy	uninflamed	NA	no	NA	10:20:00	15:00:00	Menna	1:1	tissue_v2	worthington	QR	stemcell_RT	yes	no	1	SLBZ4589	V3.1	154287	chip-g	154412	33380	6	29217280	Chromium single cell 3 prime v3	1	HG_ Mapping genetic variants underlying gene regulation in healthy intestinal cell types to identify novel IBD drug targets	5819	208297178	ti	healthy	04:40:00	Sequenced + Cell Ranger	4444	88582	1549	393661891	97.5%	78.5%	98.7%	82.1%	97.2%	98.8%	94.1%	89.5%	6.5%	28.5%	54.6%	50.2%	2.4%	85.0%	23635	4446
2020-02-03	2020-02-05	03-02-2020-001	OTARscRNA8356398	M	59	TI	Healthy	uninflamed	NA	ex-smoker	NA	10:00:00	14:30:00	Menna	1:1	tissue_v2	worthington	QR	stemcell_RT	yes	no	1	SLBZ4589	V3.1	154287	chip-g	154412	33883	3	29543619	Chromium single cell 3 prime v3	1	HG_ Mapping genetic variants underlying gene regulation in healthy intestinal cell types to identify novel IBD drug targets	5819	121800392	ti	healthy	04:30:00	Sequenced + Cell Ranger	2933	83451	1116	244763492	97.6%	67.8%	97.0%	92.0%	94.0%	96.2%	94.4%	90.5%	7.3%	21.4%	61.9%	58.4%	1.5%	83.9%	22358	4092
2020-02-05	2020-02-06	05-02-2020-002	OTARscRNA8356590	F	40	TI	Healthy	uninflamed	NA	no	NA	11:15:00	16:00:00	Menna	1:0	tissue_v2	worthington	QR	stemcell_RT	yes	no	1	SLBZ4589	V3.1	154287	chip-g	154412	33883	3	29548495	Chromium single cell 3 prime v3	1	HG_ Mapping genetic variants underlying gene regulation in healthy intestinal cell types to identify novel IBD drug targets	5819	123009910	ti	healthy	04:45:00	Sequenced + Cell Ranger	1598	137491	763	219710693	97.3%	77.2%	96.9%	91.8%	94.4%	96.2%	93.8%	88.3%	8.5%	20.4%	59.4%	56.1%	1.7%	67.8%	20632	5054
2020-02-06	2020-02-07	06-02-2020-001	OTARscRNA8356686	F	39	TI	Healthy	uninflamed	NA	no	NA	11:20:00	17:00:00	Menna	1:1	tissue_v2	worthington	QR	stemcell_RT	yes	no	1	SLBZ4589	V3.1	155089	chip-g	154412	33883	3	29548882	Chromium single cell 3 prime v3	1	HG_ Mapping genetic variants underlying gene regulation in healthy intestinal cell types to identify novel IBD drug targets	5819	140545230	ti	healthy	05:40:00	Sequenced + Cell Ranger	3841	71634	1215	275147043	97.2%	73.2%	97.0%	92.2%	93.7%	96.2%	94.1%	88.5%	8.6%	22.8%	57.1%	53.6%	1.7%	76.5%	22371	4028
2020-03-02	2020-03-03	02-03-2020-001	OTARscRNA8356782	F	48	TI	Healthy	uninflamed	NA	no	Lisa Sharkey	11:10:00	15:15:00	Menna	1:1	tissue_v2	worthington	QR	stemcell_RT	yes	no	1	SLBZ4589	V3.1	155089	chip-g	154412	33883	3	29549171	Chromium single cell 3 prime v3	1	HG_ Mapping genetic variants underlying gene regulation in healthy intestinal cell types to identify novel IBD drug targets	5819	178701422	ti	healthy	04:05:00	Sequenced + Cell Ranger	3962	69129	1497	273891010	98.1%	67.8%	97.0%	92.0%	94.7%	96.3%	95.3%	91.0%	6.8%	26.1%	58.1%	54.3%	1.6%	88.4%	22755	4613
